|
|
|
||
|
|
|
|
|
|||
| Friday, September 03, 2010 | ||
|
||||||||||||||||||||||
 |
Centre to reintroduce mono-valent vaccines in polio driveNotwithstanding the sharp differences of opinion in the review meeting of the India Expert Advisory Group (IEAG) on polio eradication, the country is set to use monovalent oral polio vaccine PCI to appoint pharmacy inspectorsto monitor medical storesPharmacy Council of India (PCI) will be appointing pharmacy inspectors in all the states in a bid to curb the practice of dispensing medicines by the unqualified persons at pharmacy counters in the country. IISc completes micestudy for malaria drugIn a major Plasmodium Falciparum malaria drug research programme in the country, Indian Institute of Science (IISc), the research partner has successfully completed the mice study using a combination Pharma cos report 40% growth in net profit during first half of 2006-07Indian Pharmaceutical companies are all set to register bumper growth in sales and profits in the current year. A Pharmabiz study of top 50 pharmaceutical companies during first six months of 2006-07 Pharmaceutical labelingThe term labelling, means all the labels and other written, printed, or graphic matter upon an immediate container of an article or upon, or in, any package. The awareness for quality brands has been risen Effectively responding to US FDA 483s and warning letters483s represent concerns noted by an FDA investigator after completion of inspection. This is the form used by investigators to record their observations of non-compliance with cGMPs. Globalisation of biotech offshoringThere are about 3,000 biotechnology companies in the world; only 100 have approved products. The rest rely on private and public equity capital markets for their survival - until they can sustain LifeCell in talks with state govt, MNCs to set up cord blood bankingLifeCell, the Chennai-based pioneer in stem cell repository and research firm, is working on how they can get government support, evaluation of technology platforms, foreign collaboration etc DBT initiative to assess quality of medical devicesThe Department of Biotechnology (DBT) under the Science and Technology Ministry is taking steps to assess the quality of existing medical devices and implants in the country, besides Excellent Half YearThe pharmaceutical industry in India presented a stunning performance during the first half of the current year. The top companies reported excellent growth in profits and sales during the first six months Preparing for a prospective pharmacy professionThere is an increasing concern about the future of pharmacy education and the effect on the profession due to the sweeping changes in all spheres of human activity because of liberalization Govt move to introduce GLP norms may hasten closure of more SSIsThe small-scale pharmaceutical manufacturers in the country, already in doldrums due to the Schedule-M norms that forced them to invest many crores of rupees on infrastructure, fear that the proposed State DIC to launch interactive software to detectdrug to drug interactionThe Drug Information Centre (DIC) of Maharashtra State Pharmacy Council (MSPC) is all set to bring out indigenous CD based interactive software to detect drug to drug interactions 'Voluntary margin cut of 886 drugs yet to reflect on retail prices'The fresh stocks of drugs with revised prices, after the industry voluntarily cut trade margins for generic medicines, were yet to be released in the market as old stocks are still to be sold, PDMA demands implementation of Dr Pronab Senand Dr Rangarajan proposalsThe Punjab Drug Manufacturers' Association (PDMA) has demanded for the implementation of the Dr Pronab Sen and Dr Rangarajan recommendations for the survival of the small-scale units in the country. DCC meeting ponders overstrengthening of regulatory systemWide-ranging issues from upgrading of regulatory system to match with the global mechanism, interstate cooperation to curb on substandard drugs movement, and to bringing in checks Indian Pharmacopoeia drafts 92 new monographsThe scientific body of the Indian Pharmacopoeia Commission (IPC) has prepared 92 new draft monographs, planning to include them in the next edition of the Indian Pharmacopoeia (IP) US initiative to improve cold chainmanagement of Indian drugsThe United States Trade and Development Agency (USTDA) may soon initiate a project to assess the cold chain management system in India related to the logistics of drugs and biologicals 'Passing of the Patent Bill in 2005 was adefining movement for pharma sector'Considering your expertise in pharma marketing and brand management, how do you react to ORG data, which is reflecting wholesale audit figures and not retail audit figures? ORG IMS reflecting The Indian scenario of Ayurveda, medicinal plantsMedicinal plants are one of the important components of biodiversity. Ayurved - A revolution aheadAyurved - the Science of Life is what we have come to learn. A deeper understanding leads us to a realisation that the ancient texts have actually prescribed an entire Way of Life. Most Ayurved enthusiasts 'AIOCD is transforming to a Corporate from the tag of a trade association'How do you assess the current status of drug trade in India? The Traders and Manufacturers are certainly a confused lot today mainly because of the lack of clarity and direction Activators ofG protein signalling: Novel partnersThe nature has its own solutions for communications among trillions of cells that are remotely located through out the living system. The cells being unit of life and nucleus being the center Schwarz in marketing pact with Otsuka for Pletal in GermanySchwarz Pharma announced that Schwarz Pharma Deutschland GmbH has signed an agreement with Otsuka Pharmaceutical Europe Ltd., UK on the joint marketing of Pletal in Germany. Dr Reddy's to market Torrent's drugs in RussiaDr Reddy's Laboratories Ltd informed that the company and Torrent Pharmaceuticals Ltd have concluded an exclusive agreement for commercialisation of two of Torrent's brands in Russia, viz. Listril MEF in making to promote indigenous designing of devicesDifferent stakeholders, from hospitals to doctors, from NGOs to the government bodies are joining hands to form a forum under the aegis of FICCI to promote indigenous designing and manufacturing of the devices. Cinvention sees huge potential for drug eluting stents marketThe Germany-based Cinvention AG, a leading technology company focusing on nano-composite materials in biomedical applications is pitching on drug eluting stents market globally. Glenmark receives 25m euro payment from MerckGlenmark Pharmaceuticals S.A. [GPSA], the wholly owned Swiss subsidiary of Glenmark Pharmaceuticals Ltd. [India] [Glenmark] has, after the anti-trust clearance in the US, received Euro 25 million Our Bureau, MumbaiLupin Ltd has announced that the US FDA has granted tentative approval for the company's Abbreviated New Drug Application (ANDA) for trandolapril tablets, 1 mg, 2 mg and 4 mg. Venus Remedies' Baddi facility gets Columbian approvalVenus Remedies Ltd has bagged the INVIMA certification for its Baddi facilities from the Columbian Drug Authorities.This GMP certification was granted after a week long inspection by a team JB Chemicals to investUS$ 5.1 mn in Biotech Labs, SAJB Chemicals & Pharmaceuticals Ltd (JBCPL) has signed a definitive agreement to make a strategic investment of US$ 5.1 million in Biotech Laaboratories (Pty) Ltd. (Biotech) of South Africa. Akorn, Strides Arcolab expandproduct pipeline to 29 ANDAsAkorn Inc. and Strides Arcolab Limited have agreed to fund, develop, and commercialise an additional 10 ANDAs (Abbreviated New Drug Application) injectable drug products for the Akorn-Strides, LLC joint venture. Lal PathLabs plans 50 new labs across India by 2009Dr Lal PathLabs, the pathology chain based in New Delhi, is planning to set up a network of 50 laboratories across the country by March 2009. With 30 per cent growth in CAGR for last five years, Ranbaxy gets US FDA nod for cefprozileffect as that of the reference listed drug Cefzil tablets, 250 mg and 500 mg, respectively, of Bristol Myers Squibb Company Pharmaceutical Research Institute. Cefzil is the registered trademark Centre to create global tech acquisition fund to support Indian company acquisitions abroadUnion government is working to create a global technology acquisition fund to support the Indian company acquisitions abroad. Companies in India are on aggressive mode to acquire medium Glenmark's pain molecule GRC 6211 to enter for phase I trial in EuropeGlenmark Pharmaceuticals S.A. [GPSA], the wholly owned Swiss subsidiary of Glenmark Pharmaceuticals Ltd. [Glenmark], has applied for phase I clinical trials in Europe, for GRC 6211 Serono starts Rebif phase III trialSerono has announced the initiation of a phase III clinical trial to evaluate the effect of two dosage regimens of the new formulation of Rebif (interferon beta-1a 44 mcg, three times a week or once a week) on the time New platelet drug well tolerated: AmgenAmgen has announced interim results from an open-label extension study showing that long-term administration (up to 48 weeks) of its investigational therapy AMG 531 stimulated platelet GSK's eltrombopag cuts down bleeding episodes: StudyGlaxoSmithKline (GSK) has announced additional results from an international phase II short-term, six-week study of its investigational non-peptide oral platelet growth factor, eltrombopag. Genentech's renal cancer drug trial meets endpointGenentech Inc. has announced that an interim analysis shows that a randomised phase III clinical study of Avastin (bevacizumab) in combination with interferon alfa-2a therapy in patients with first-line GSK, EPIX tie up for drug discovery and developmentGlaxoSmithKline (GSK) and EPIX Pharmaceuticals has announced a worldwide multi-target strategic collaboration to discover, develop and market novel medicines targeting four Celgene acquires API facility in Europe from SiegfriedCelgene Corporation has acquired active pharmaceutical ingredient (API) manufacturing facility from Siegfried Ltd, a manufacturer of high-quality pharmaceutical products located in Zofingen Bayer MaterialScience expands MDI production capacityBayer MaterialScience AG has now completed the expansion of its production facilities for methylene diphenyl diisocyanate (MDI) in Tarragona, Spain by 50,000 tons a year to an annual capacity of 150,000 tons. Sanofi completes shipment of50 mn doses for flu vaccine to USSanofi pasteur, the vaccines business of the sanofi-aventis Group, has completed shipping 50 million doses of influenza vaccine (Fluzone, Influenza Virus Vaccine) to the US market, fulfilling its original production WHO report identifies large untapped global market for TB testsA significant and largely untapped global market exists for more effective and affordable tests to diagnose TB in low- and middle-income countries, where most TB cases occur. Centre to make compulsoryfiling of ISM raw material data with central, state agenciesAs part of bringing in more central control over manufacturing and sales of Ayurveda, Siddha and Unani drugs in the country, the central government will soon amend the Drugs and Cosmetics AVN signs MoU withUniversity of Toronto forresearch on diabetes, obesityThe Madurai based Arya Vaidya Nilayam (AVN), one of the oldest Ayurveda drug manufacturing company and treatment centre, has a signed an MoU and confidentiality agreement with Bipha to venture into Tamil Nadu and AndhraBipha Drug Laboratories, one of the oldest pharmaceutical and ayurvedic drug manufacturer in Kerala, will foray into Tamil Nadu by January 2007 and is planning to expand its operations IICT sets up herbo-metallic products testing facilityThe Indian Institute of Chemical Technology (IICT) has set up a national facility for analysis of herbo-metallic products. The facility was formally inaugurated on Tuesday at its premises in Hyderabad. Botswana seeks investments from Indian pharma industryThe Republic of Botswana is seeking investments from Indian pharmaceuticals industry. India and Botswana have been witnessing a steady growth in trade and services between the two countries Pharmexcil to organise meeting to sort out export issuesThe Pharmaceutical Export Promotion Council (Pharmexcil) is organising an interactive meeting on December 23, 2006 in Mumbai to discuss the issues related to pharma exports. Venus Remedies launches new antibiotic productVenus Remedies Ltd has launched antibiotic, Mucomelt-Forte. The company is planning to launch new products in near future for domestic market. The Biocard division of the company has launched Elder Pharmaceuticals ties up with Roche to market Bonviva in IndiaThe Mumbai-based Elder Pharmaceuticals Ltd has tied up with F Hoffmann La Roche Ltd., Basle, Switzerland to market its postmenopausal osteoporosis drug Bonviva in India. Reddy's to launch polypill to treat CVD next yearDr Reddy's Laboratories will launch polypill, a combination of now widely used four medicines to treat cardiac diseases vastly simpler and more effectively, in India by the second quarter Sigma-Aldrich signs pact with Rubicon for RNA technologySigma-Aldrich, a $1.7 billion Life Science and high technology company, has announced an exclusive licensing agreement with Rubicon Genomics to further develop and commercialize Misonix developes Sonatherm 600 for treatment of soft tissueMisonix, Inc., a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, announced its plans to bring the Sonatherm 600, (Sonatherm) New Delhi to host HOSPIMedica India 2007HOSPIMedica India 2007, the 13th international exhibition and conference on diagnostics, medical equipment and technology, will be held from 9th to 11th March 2007, at Pragati Maidan, AIPS to start diploma course in patent managementThe Academy of Intellectual Property Studies (AIPS) in association with the Indian Drug Manufacturers' Association (IDMA), is inviting registrations to the next batch of its one-year, Beijing to host AchemAsia 2007on May 14-18, 2007ACHEMA, the world's leading event for chemical engineering and biotechnology, is the global platform for the process industries. Already the 7th successful event in a row, AchemAsia 2007 ONCO Life Sciences to conduct seminar on cGMPs, GLPs and US FDA inspection at MumbaiA three-day training seminar on cGMPs, GLPs and US FDA inspection will be conducted by the Pune-based ONCO Life Sciences in collaboration with SPI USA, Baltimore from 19 to 21 March 2007 at Mumbai. New Frontiers 2007 pharmacy trade meet to attract Indian pharmacy cosThe company Chemists' Association, the UK-based pharmacy organisation is on plans to attract the Indian companies towards its upcoming unique UK pharmacy trade event, New Frontiers 2007. Cuts into diclofenac market, 10 brands availablePost diclofenac ban, Indian companies have come out with at least 10 brands of its safe alternative, the non-steroidal anti inflammatory (NSAID) drug meloxicam, for veterinary use. TN Pharmacy Council to set up drug information centre by Feb 2007The Tamil Nadu Pharmacy Council will be setting up a drug information centre with a total investment of around Rs 20 lakhs in its premises by February 2007. The council is planning to get the centre on the moveA look at some of the top management moves in the Indian pharma industry in 2006 KIMMA objects to central notification for product registration, licensing of ISM drugsKarnataka Indian System of Medicines Manufacturers' Association (KIMMA) has criticized the central government notification to amend the Drugs & Cosmetics Act 1940 which calls for centralized product registration |
|
|
|||||||||||||||||||
